Didanosine (Videx)

Published January 25, 2001; Updated August 15, 2012
Susa Coffey, MD
Selected Reference
5. Jemsek J, Hutcherson P, and Harper E. Poor virologic responses and early emergence of resistance in treatment naive, HIV-infected patients receiving a once daily triple nucleoside regimen of didanosine, lamivudine, and tenofovir DF. In: Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco. Abstract 51.